KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements. (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-020-1001-z
PubMed Identifier: 32764680
Publication URI: http://europepmc.org/abstract/MED/32764680
Type: Journal Article/Review
Volume: 35
Parent Publication: Leukemia
Issue: 4
ISSN: 0887-6924